ByteBrief
We're a portrait publication through and through. Turn your phone back and your briefing picks up right where you left it.
(We tried widescreen once. It wasn't us.)

At The Briefing: AI for Science event earlier this week, Anthropic announced Claude Science and declared it will develop treatments for neglected diseases. Head of life sciences Eric Kauderer-Abrams stated the company focuses on discovering therapies while hiring biologists to build wet labs. Experts note that no AI-designed drug has yet reached market approval despite active recruitment in life sciences roles.
Tap to vote and see what everyone thinks.
Summary by ByteBrief